The lncRNA MAFG-divergent transcript (MAFG DT) has been shown to be upregulated in pancreatic cancer, colorectal cancer, bladder cancer, and gastric cancer, and it promotes tumor progression (17–20). This evidence concerns the gene MAFG and urinary bladder carcinoma.